This bill directs the NIH and USPSTF to study hormone variability before perimenopause and the clinical usefulness of hormone testing for perimenopause management.
Hillary Scholten
Representative
MI-3
This bill directs the National Institutes of Health (NIH) to study natural hormone variability in women before perimenopause. It also requires the U.S. Preventive Services Task Force to review the clinical usefulness of hormone testing for diagnosing or managing perimenopause. The findings and recommendations will be reported to Congress within 18 months of enactment.
Hormone Health Data and Research Act Mandates Federal Review of Perimenopause Testing and Baseline Data Within 18 Months
The Hormone Health Data and Research Act aims to bridge the information gap in women’s healthcare by requiring federal health agencies to deep-dive into the science of perimenopause. Specifically, the bill tasks the National Institutes of Health (NIH) with evaluating all existing evidence on how hormone levels fluctuate in women before they hit the perimenopause transition (Section 2). For anyone who has ever wondered if their 'normal' is actually normal, this provision seeks to establish a baseline for hormone variability that currently lacks a clear, standardized definition in the medical community.
Mapping the Hormonal Landscape
Beyond just looking at data, the bill requires the U.S. Preventive Services Task Force (USPSTF) to determine if hormone testing is actually a useful tool for diagnosing perimenopause (Section 2). Currently, many women in their 30s and 40s may pay for expensive blood work or saliva tests that provide a snapshot of their hormones, but there is significant debate over whether these tests help doctors manage symptoms effectively. By reviewing the clinical usefulness of these tests, the bill aims to clarify if early testing should become a standard part of preventative care or if it’s an unnecessary expense that doesn't change the treatment plan.
The 18-Month Deadline for Answers
This isn't a project that can sit on a shelf indefinitely. The legislation requires the NIH and the Secretary of Health and Human Services to deliver a joint report to several high-level Congressional committees no later than 18 months after the bill is signed into law (Section 2). This report must not only summarize what we already know but also explicitly point out where the science is missing and provide a roadmap for future research. For a working professional or a busy parent trying to navigate brain fog, sleep issues, or mood changes, this report could eventually lead to more accurate diagnoses and better-informed conversations with their primary care physician.